BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

RetroSense Therapeutics 

2725 S. Industrial Highway, Suite 200

Ann Arbor  Michigan  48104  U.S.A.
Phone: 248-924-3298 Fax:


SEARCH JOBS




Industry
Technology

Segment
Gene Therapy





 Company News
RetroSense Therapeutics Selected As Finalist For Prestigious Angel Investor Award 4/8/2015 12:19:06 PM
RetroSense Therapeutics To Present At 7th Annual Biotech Showcase Conference 1/12/2015 10:38:34 AM
RetroSense Therapeutics Raises $6 Million In Series A Financing To Further Develop Lead Product RST-001 For Retinitis Pigmentosa 1/8/2015 10:40:48 AM
RetroSense Therapeutics Receives Second "Top Project To Watch" Nomination 11/20/2014 1:54:52 PM
RetroSense Therapeutics Signs License Agreement With Massachusetts General Hospital, Expanding Its Optogenetics Intellectual Property Portfolio 11/17/2014 12:32:31 PM
RetroSense Therapeutics Granted Orphan Drug Designation For Lead Product RST-001 For Retinitis Pigmentosa 10/30/2014 11:20:51 AM
RetroSense Therapeutics Selected by Windhover Information Inc. as a "Top Project to Watch: Most Licensable Product" 10/29/2013 10:01:48 AM
RetroSense Therapeutics Announces Exclusive Option to Intellectual Property Covering Vision Augmentation From Massachusetts General Hospital 3/27/2013 10:53:53 AM
RetroSense Therapeutics Announces Notice of Allowance for New U.S. Patent Application Broadly Covering Optogenetic Approaches to Vision Restoration 3/5/2013 9:31:22 AM
RetroSense Therapeutics Welcomes Dr. Steven Bramer as Chief Development Officer 10/4/2012 10:19:18 AM
12